Showing posts with label leaky gut syndrome. Show all posts
Showing posts with label leaky gut syndrome. Show all posts

Wednesday, July 12, 2017

Weight Control, Glucose Sensitivity, and the other Benefits of B. Lactis B420

As the research on probiotics continues to mushroom, some very compelling applications are being shown that would not have previously been attributed to the microbiome.  

Along those lines, then, there's some very interesting research surrounding a new probiotic strain called, Bifidobacterium Lactis B420.  

Now, before we examine the research on this strain, let's first note that medical science is beginning to make a connection between body weight and gut microbiota.  This was first discovered by accident with fecal implant patients.  Doctors began to notice that recipients of fecal implants would take on the characteristics of the donor in terms of body composition.  So a study was done on mice to try to reproduce this, and indeed they found the same thing in the laboratory.  A fecal sample was taken from an obese person and implanted into a mouse, and the mouse gained weight. 

So enter, then, the research on B. Lactis B420. 

Before we look at the research specific to body weight, let’s first look at the various other benefits of this impressive strain on other health paramters.

Experimental research has indicated that:

  • B420 increased tight junction integrity of epithelial cells, and therefore protected gut epithelial cells from the harmful effects of pathogenic microbes.
  • B420 protected against NSAID-induced GI side effects in a rat model by reducing an NSAID-induced inrease in stomach permeability
  • B420 reduced mucosal dysbiosis, bacterial translocation, expression of major pro-inflammatory cytokines in various tissues, and improved glucose metabolism in mice fed a high fat diet (HFD).
  • In HFD-fed mice, B420 modulated gut microbiota and improved glucose intolerance.  Further, the combination prevented the impairment of intestinal immunity due to metabolic abnormalities induded by the HFD.
  • In a mouse model of diabetes, B420 enhanced concentrations of ileum GLP-1, a protein involved in both insulin secretion and satiety signaling.
  • In an obese mouse model, increases in body weight and fat mass in mice fed with HFD for 12 weeks were significantly reduced if the mice were co-administered B420.  
  • In a diabetes mouse model, mice receiving both HFD and B420 had decreased fat mass compared with mice receiving only HFD.  B420 also improved glucose metabolism in this mouse model.


So this is already a very impressive list of benefits even without the benefits of weight control.  But now let’s turn our attention to that aspect, which is human data.

The goal here was to determine if the B420 could make a change in the incremental body weight that many people experience over time as they age.  The untreated group of overweight individuals gained 3.1% of bodyweight in six months.  The overweight group receiving 10 billion units per day of the B420 probiotic strain, however, did not gain any extra body weight in that same period of time, and they observed no dietary or lifestyle changes.  All they did was add the probiotic.  The probiotic group also showed a slight decrease in waist circumference of 2.4%, AND they ate less, showing improved satiety with the use of the probiotic strain. 

Another very positive benefit was the improvement in short chain fatty acids over that period of time, a huge benefit to gut health. 

Now, as we know, many people tend to gain weight as they age, some a little, and some a lot.  It’s too early to tell if the B420 can legitimately be called a weight LOSS probiotic, but it can certainly be called a weight CONTROL probiotic.  With that in mind, remember that those in the study didn’t change anything about their lifestyles.  So it could be, perhaps, that if this probiotic strain was added to a weight loss plan, it may amplify the effects of the other weight loss efforts….maybe.  Again, there’s not enough information to go on yet to verify that statement, but I think it’s a fairly good assumption that this could be the case. 

I’ll close by saying that weight gain with age is multi-factorial, and can be attributed to shifts in hormones and other factors.  However, we cannot and should not rule out the changes in the microbiome that occur with age as well.  And weight issues aside, there are enough other benefits with this remarkable strain that it should be considered for use with leaky gut and autoimmune patients, those with gut dysbiosis, and even glucose and insulin intolerance. 

References available upon request



Friday, September 30, 2016

Amazing Novel Ingredients for Gut Healing

More than 70 million Americans suffer from chronic digestive disorders, and gastrointestinal issues are the most common reason for hospitalization.  

While there are a number of health promoting natural agents in nature's pharmacy, health science continues to uncover new and novel ingredients to heal the gut in unique ways.  

2-Fucosyllactose
Enter, then, 2-fucosyllactose (2-FL).  2-FL is a nature-identical Human Milk Oligosaccharide, the most abundant prebiotic found in human breast milk.

Several functions have been attributed to 2-FL, including the ability to support the growth of beneficial microbiota and significant increased production of short chain fatty acids, including butyrate, and the ability to increase and normalize motility.  

2-FL also works by blocking potentially harmful pathogenic bacteria from adhering to host cell receptors by acting as a decoy molecule.  In other words, instead of adhering to intestinal epithelial cells, pathogens will be attracted to the 2-FL, binding to it and hence being escorted out of the body in the stool.  In research, 2-FL has been shown to act as an anti-adhesive antimicrobial to campylobacter jejuni, vibrio cholera, E. coli, and norovirus.  

In fact, in a 6-week trial at the Functional Medicine Research Center (FMRC) in Gig Harbor, Washington, a functional food drink mix containing 2-FL was given to patients with previously diagnosed IBS, IBD, and celiac disease.  In that study, 8 potentially harmful bacteria were identified at baseline.  At the end of the study, 7 of the 8 total pathogen species were no longer detected.  

Butyrate and Short Chain Fatty Acids
Interest has been recently rekindled in short chain fatty acids (SCFAs) with the emergence of prebiotics and probiotics aimed at improving colonic and systemic health. SFCAs include the sum of butyrate, acetate, and propionate.  

Butyrate is the major energy source for colonocytes and is considered an anti-inflammatory fat. Butyrate also helps to support apoptosis of the cells lining the gut, and is the most important source of energy for those cells.  (More on butyrate here.)

Specific SCFA may reduce the risk of developing gastrointestinal disorders, cancer, and cardiovascular disease. Acetate is the principal SCFA in the colon. Propionate, a gluconeogenerator, has been shown to inhibit cholesterol synthesis. 

In that same study at the FMRC featuring the functional food containing 2-FL, total SCFA increased by a mean of 72.2%, and butyrate alone increased by a mean of 72.7%, an amazing increase in these health-promoting fatty acids. 

Huge Bifidobacteria Proliferation   
It's one thing to give probiotics to help supply the GI with beneficial bacteria, and that is always a good thing.  But helping the bacteria that is already there to multiply is also extremely helpful for the microbiota.  

Isomalto-oligosaccharides (IMOs) are a prebiotic soluble fiber and help to increase the growth of bifidobacteria, which 2-FL also does.  In the aforementioned study on patients with previously diagnosed celiac, IBD, and IBS, bifidobacteria increased by an astounding 1900% in 6 weeks!  

It is no surprise, then, that patients in this study showed significantly improved quality of life scores.

A Better Form of L-Glutamine
Glutamine is an important amino acid for epithelial cell repair and function.  What is not as widely known is that L-glutamine in the free form, which is the most commonly used form, is not as well absorbed as the dipeptide version.  "Sustamine" is an L-Alanyl-L-Glutamine dipetide that is designed to be absorbed faster and with less energy than a single amino acid.  Dipetides and amino acids require a transporter to carried across the cell membranes.  This helps to facilitate absorption.  In fact, Sustamine has been shown to be absorbed 224% better than free from L-glutamine, possibly demonstrating better clinical outcomes at lower doses.  

This form of dipeptide L-glutamine is also featured in the functional food studied at the FMRC, and this, combined with the 2-FL, IMOs, and other supportive macro and micronutrients, makes it a very good choice for nutritional support for health conditions related to intestinal permeability, as well as providing excellent nutrition for celiac, IBD, and IBS patients.